Paving the Way for eHealth Interoperability: The EURO-CAS Project Launches Today

The EURO-CAS project launched operations today to deliver the eHealth Conformity Assessment Scheme for Europe in 2018. This scheme will help European health systems assess the conformity of eHealth products and solutions with international standards, and will enhance vendors' visibility by offering public recognition of conformity of their products. This will advance eHealth interoperability, help advance the European Digital Single Market in the health and care domain, and facilitate the sharing of information for better and more person-centred healthcare.

Led by IHE-Europe, a recognised leader in eHealth standards, the EURO-CAS consortium consists of representatives and competence centres of key European regions and Member States, as well as experts and international associations. Together they will assess the interoperability requirements of European health systems and analyse the existing testing and certification schemes, before developing and testing a European conformity scheme in several regions, guided by an advisory board of additional experts and policymakers. The finalised EURO-CAS model will be presented in November 2018 to the public.

"Lack of interoperability is both a reason for, and a result of, the fragmentation of eHealth markets in Europe and the endurance of information silos," says Karima Bourquard, Director of interoperability at IHE Europe, and scientific coordinator of EURO-CAS. "The EURO-CAS conformity assessment scheme will provide a comprehensive framework, with flexibility to allow better sustainability and harmonisation at European, national and regional levels."

EURO-CAS will build on the findings and results of a series of EU-funded projects that have advanced eHealth interoperability within and between Member States in the last years, and will provide a scheme consistent with the Refined eHealth European Interoperability Framework endorsed by representatives of all 28 European Member States in 2015.

The EURO-CAS conformity assessment scheme for Europe will consist of models, processes and tools that will enable and strengthen the capability of test centres to assess eHealth product and solutions, not only in regard to international standards and interoperability requirements of European eHealth projects, but also in regard to national and regional eHealth requirements.

The EURO-CAS project is committed to transparency and openness, and invites interested parties to join and contribute. They can engage face to face with consortium members during EURO-CAS events, or offer comments and feedback to key deliverables that will be offered for public consultation.

For further information, please visit:
http://www.euro-cas.eu

About the EURO-CAS project

The European eHealth Interoperability Conformity Assessment Scheme for Europe (EURO-CAS) will between 2016 and 2018 develop the sustainable Conformity Assessment Scheme (CAS) for Europe, which will promote the adoption and take-up of interoperability testing of eHealth solutions against identified eHealth standards and profiles defined in the eHealth European Interoperability Framework (eEIF). The project is led by IHE Europe (BE) and coordinated by EIBIR (AT), and joined by fourteen national and regional government bodies, competence centres, and associations. The EURO-CAS project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No. 727028.

Most Popular Now

Moderna and IBM Plan to Collaborate on C…

Moderna (Nasdaq: MRNA) and IBM (NYSE: IBM) announced their intentions to explore technologies, including artificial intelligence, blockchain and hybrid cloud, that could help support smarter COVID-19 vaccine management. Central to...

Early Warning System for Intensive Care …

Life-threatening situations occur time and again in an intensive care unit. To make sure that doctors can intervene in time, a team at the German Heart Center Berlin (DHZB) has...

Virtual Reality could Help to Reduce Pai…

We all feel physical pain in different ways, but people with nerve injuries often have a dysfunctional pain suppression system, making them particularly prone to discomfort. Now researchers have uncovered that...

East Lancashire Signs Deal for Early War…

Thousands of NHS professionals across five hospitals in East Lancashire are to benefit from early warning technology that will help them detect and swiftly respond to deteriorating patients in need...

Philips Partners with Orbita to Develop …

Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, and Orbita Inc., an innovative provider of conversational artificial intelligence (AI) solutions for healthcare, announced a partnership agreement...

CliniSys Group Creates Single Brand for …

CliniSys Group has created a single brand for its businesses in the UK and Europe, with a refreshed logo and a new website. The move creates a unified identity for CliniSys...

DMEA 2021: Digital Health. 100 % Virtual…

7 - 11 June 2021, Berlin, Germany. An entire week dominated by digital healthcare! With that in mind, early in June DMEA 2021 will be kicking off with a wide range...

FDA Grants Oxehealth Vital Signs De Novo…

Oxehealth has announced another world first after the US Food and Drug Administration granted a De Novo clearance for its Oxehealth Vital Signs product, which is incorporated into Oxevision, the...

Child Brain Tumours can be Classified by…

Diffusion weighted imaging and machine learning can successfully classify the diagnosis and characteristics of common types of paediatric brain tumours a UK-based multi-centre study, including WMG at the University of...

Telemedicine Improves Access to High-Qua…

The American Academy of Sleep Medicine recently published an update on the use of telemedicine for the diagnosis and treatment of sleep disorders to reflect lessons learned from the transition...

Philips and NHS Implement the First Regi…

Royal Philips (NYSE: PHG, AEX: PHIA), announced it has supported the NHS' Cheshire and Merseyside consortium [1] to become the first regional hub supplying the United Kingdom's National COVID-19 Chest...